Follicle stimulating hormone as a predictor of ovarian response in women undergoing controlled ovarian hyperstimulation for IVF

被引:31
|
作者
Ashrafi, M
Madani, T
Tehranian, AS
Malekzadeh, F
机构
[1] Royan Inst, Dept Endocrinol & Female Infertil, Tehran, Iran
[2] Iran Univ, Akbar Abadi Hosp, Med Sci & Hlth Serv, Tehran, Iran
[3] Azad Univ Islam Med Sci, Tehran, Iran
关键词
controlled ovarian hyperstimulation; follicle stimulating hormone level at day 3; oocyte; in vitro fertilization; poor ovarian response;
D O I
10.1016/j.ijgo.2005.06.017
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate the effect of basal follicle stimulating hormone (FHS) level on ovarian response in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Methods: A descriptive and analytic study of 212 cycles of IVF chosen from about 2200 files of women treated at Royan Institute, Tehran, Iran, from 1991 to 1999. Treatment was started with intranasal or subcutaneous buserlin (0.5 cm(3)), on day 21 (long protocol). On day 2 of the next cycle, stimulation with human menopausal gonadotropin (hMG) was initiated. When the number and size of follicles were suitable, human chorionic gonadotropin (hCG) was given intramuscularly for ovulation induction, followed by oocyte retrieval 36 to 40 h later. Embryos were transferred about 48 to 72 h after oocyte retrieval. The women were assigned to 2 groups on the basis of day 3 serum FSH levels (>= 15 IU/mL, group 1 and < 15 IU/mL, group 2). Results: There were statistically significant differences between the 2 groups in number of follicles, number of oocytes retrieved and embryos transferred (lower in group 1), and level of serum luteinizing hormone and number of canceled cycles (higher in group 1). There were no statistical differences in number of ampoules of hMG used or age of patients. Conclusion: Day-3 serum FSH level was a predictor of ovarian response and IVF outcome in this study. (c) 2005 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:53 / 57
页数:5
相关论文
共 50 条
  • [21] Modeling Follicle Stimulating Hormone (FSH) Levels in Serum for Controlled Ovarian Hyperstimulation II: The Underlying Mechanisms
    McCulloh, David H.
    Colon, Jose M.
    McGovern, Peter G.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2012, 13 (03) : 444 - 453
  • [22] Cycle Day 5 Follicle Stimulating Hormone Levels Predict HCG Levels in Controlled Ovarian Hyperstimulation
    Burks, H.
    Paulson, E.
    Opper, N.
    Stanczyk, F.
    Paulson, R.
    FERTILITY AND STERILITY, 2014, 101 (02) : E17 - E17
  • [23] The use of a starting dose of recombinant follicle stimulating hormone for controlled ovarian hyperstimulation: a randomized pilot study
    Battaglia, C
    Regnani, G
    Petraglia, F
    Genazzani, AR
    Artini, PG
    Volpe, A
    GYNECOLOGICAL ENDOCRINOLOGY, 2000, 14 (05) : 311 - 315
  • [24] Poor ovarian response as a predictor for live birth in older women undergoing IVF
    Cohen, Yoni
    Tannus, Samer
    Alzawawi, Nabigah
    Son, Weon-Young
    Dahan, Michael
    Buckett, William
    REPRODUCTIVE BIOMEDICINE ONLINE, 2018, 36 (04) : 435 - 441
  • [25] Modeling Follicle Stimulating Hormone Levels in Serum for Controlled Ovarian Hyperstimulation I: Comparing Gonadotropin Products
    McCulloh, David H.
    Maseelall, Priya
    Colon, Jose M.
    McGovern, Peter G.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2012, 13 (03) : 435 - 443
  • [26] Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor
    Smits, G
    Olatunbosun, O
    Delbaere, A
    Pierson, R
    Vassart, G
    Costagliola, S
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (08): : 760 - 766
  • [27] Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor
    Delbaere, A
    BIOMEDICINE & PHARMACOTHERAPY, 2004, 58 (6-7) : 407 - 407
  • [28] Association of follicle stimulating hormone (FSH) receptor gene polymorphisms with outcome of controlled ovarian stimulation in patients undergoing IVF.
    Lee, H
    Cha, S
    Choi, H
    Kang, H
    Koong, M
    Jun, J
    FERTILITY AND STERILITY, 2005, 84 : S413 - S413
  • [29] The role of follicle stimulating hormone receptor gene polymorphisms in the prediction of ovarian response to controlled ovarian stimulation
    Nardo, L. G.
    Mohiyiddeen, L.
    Mulugeta, B.
    McBurney, H.
    Roberts, S. A.
    Newman, W. G.
    HUMAN REPRODUCTION, 2011, 26 : I301 - I301
  • [30] Follicle stimulating hormone secreting pituitary microadenoma with fluctuating levels of ovarian hyperstimulation
    Maruyama, T
    Masuda, H
    Uchida, H
    Nagashima, T
    Yoshimura, Y
    OBSTETRICS AND GYNECOLOGY, 2005, 105 (05): : 1215 - 1218